mounjaro patent expiration tirzepatide patent expiry Generic Mounjaro, Zepbound applications await FDA approval Semaglutide Generics to Launch in

patients who did not work with a Nourish RD 60% of Nourish patients who discontinued GLP-1s found Nourish helpful in maintaining their weight post-treatment Nourish programs drive meaningful cost savings for employers ($2.1M for an employer with 10K employees) by avoiding wasted spend and optimizing for greater results These outcomes show that pairing GLP-1 treatment with personalized, insurance-covered nutrition care from Nourish makes a measurable difference in long-term results

Compounded tirzepatide is prepared by licensed 503A pharmacies and shipped directly to you, serving all 50 states with no insurance requirement or membership fees

The short half-life of approximately 28 minutes is a therapeutic challenge

In August last year, Williams said she was taking a weight-loss medication, Zepbound, after struggling to shed kilograms through dieting and exercise after her two pregnancies